SCHEMBL24460758

SCHEMBL24460758

Nc1ccc(CN2CCCC(c3ccc(N)cc3)C2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.59
▸ CNR2 P34972 1/20 0.51
▸ LMNA P02545 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HRH3 Q9Y5N1 2/20 0.46
▸ PDE2A O00408 1/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ DRD5 P21918 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ ROCK2 O75116 1/20 0.45
▸ CCR2 P41597 1/20 0.45
▸ ROCK1 Q13464 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24460772 0.94 ALDH1A1 (0.53) ALDH1A1CNR2LMNAGAACYP1A2
SCHEMBL24460951 0.89 ALDH1A1 (0.48) ALDH1A1CNR2LMNAGAACYP1A2
SCHEMBL24460737 0.89 ALDH1A1 (0.48) ALDH1A1CNR2LMNAGAACYP1A2
SCHEMBL24460624 0.85 GAA (0.58) ALDH1A1CNR2GAACYP1A2CYP3A4
SCHEMBL9660685 0.84 DRD2 (0.50) DRD2DRD1DRD4DRD5DRD3
SCHEMBL4275131 0.81 ALDH1A1 (0.59) ALDH1A1LMNAGAACYP1A2CYP3A4
SCHEMBL1955800 0.81 ALDH1A1 (0.71) ALDH1A1LMNAGAACYP1A2CYP3A4
SCHEMBL6189062 0.81 ALDH1A1 (0.59) ALDH1A1LMNAGAACYP1A2CYP3A4
SCHEMBL1547055 0.79 DRD4 (0.72) DRD2DRD1DRD4DRD5DRD3
SCHEMBL1546881 0.79 DRD4 (0.72) DRD2DRD1DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109209-A1 SMALL MOLECULE COMPOUNDS AND COMPOSITIONS TELO THERAPEUTICS, INC. (US) 2022-05-27 — — WO disclosed
Send feedback